Upadacitinib for moderate to severe atopic dermatitis with generalized prurigo nodularis

被引:0
|
作者
Lou, Fanglu [1 ,2 ,3 ,4 ]
Wang, Yuyi [1 ,2 ,3 ,4 ]
Xiao, Yujuan [1 ,2 ,3 ,4 ]
Liu, Yi [1 ,2 ,3 ,4 ]
机构
[1] Chongqing Coll Tradit Chinese Med, Affiliated Hosp 1, Dept Dermatol, Chongqing 400011, Peoples R China
[2] Chongqing Hosp Tradit Chinese Med, Dept Dermatol, 40 Daomenkou St, Chongqing 400011, Peoples R China
[3] Chongqing Key Lab Integrat Dermatol Res, Chongqing, Peoples R China
[4] Chongqing Clin Res Ctr Dermatol, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.asjsur.2024.02.127
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:3084 / 3088
页数:5
相关论文
共 50 条
  • [1] Upadacitinib for moderate to severe atopic dermatitis
    Navarro-Trivino, Francisco
    Alcantara-Luna, Sara
    Dominguez-Cruz, Javier
    Galan-Gutierrez, Manuel
    Ruiz-Villaverde, Ricardo
    Pereyra-Rodriguez, Jose-Juan
    Armario-Hita, Jose-Carlos
    IMMUNOTHERAPY, 2023, 15 (11) : 799 - 808
  • [2] Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study
    Pezzolo, Elena
    Narcisi, Alessandra
    Gargiulo, Luigi
    Di Lernia, Vito
    Napolitano, Maddalena
    Patruno, Cataldo
    Ribero, Simone
    Ortoncelli, Michela
    Foti, Caterina
    Romita, Paolo
    Gurioli, Carlotta
    Schena, Donatella
    Ferrucci, Silvia Mariel
    Barei, Francesca
    Amoruso, Giuseppe Fabrizio
    Russo, Filomena
    Naldi, Luigi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (05) : e147 - e150
  • [3] Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis
    Napolitano, Maddalena
    Fabbrocini, Gabriella
    Scalvenzi, Massimiliano
    Nistico, Steven Paul
    Dastoli, Stefano
    Patruno, Cataldo
    DERMATITIS, 2020, 31 (01) : 81 - 84
  • [4] FILAGGRIN MUTATION-ASSOCIATED ATOPIC DERMATITIS WITH PRURIGO NODULARIS
    Uong, P.
    Abbott, J.
    Hauk, P.
    Brar, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S120 - S121
  • [5] Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
    Edwards, Steven J.
    Karner, Charlotta
    Jhita, Tracey
    Barton, Samantha
    Marceniuk, Gemma
    Yiu, Zenas Z. N.
    Wittmann, Miriam
    HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (04)
  • [6] A Case of Linear Exacerbation of Atopic Dermatitis with Secondary Prurigo Nodularis
    Kang, Hyun Jin
    Kim, Hyo Jung
    Han, Ju Hee
    Bang, Chul Hwan
    Kim, Tae-Yoon
    ANNALS OF DERMATOLOGY, 2022, 34 (04) : 297 - 300
  • [7] CONGENITAL HYPOGAMMAGLOBULINEMIA ATOPIC DERMATITIS PRURIGO NODULARIS WITH SUPERIMPOSED INFECTION
    FARBER, EM
    SEVERIN, GL
    ARCHIVES OF DERMATOLOGY, 1966, 93 (04) : 476 - &
  • [8] Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis
    Staender, Sonja
    Yosipovitch, Gil
    Legat, Franz J.
    Lacour, Jean-Philippe
    Paul, Carle
    Narbutt, Joanna
    Bieber, Thomas
    Misery, Laurent
    Wollenberg, Andreas
    Reich, Adam
    Ahmad, Faiz
    Piketty, Christophe
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 706 - 716
  • [9] Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis
    Foelster-Holst, Regina
    Reimer, Rahel
    Neumann, Claudia
    Proksch, Erhardt
    Rodriguez, Elke
    Weidinger, Stephan
    Goldust, Mohamad
    Hanisch, Eckhard
    Daehnhardt-Pfeiffer, Stephan
    Freitag-Wolf, Sandra
    BIOLOGY-BASEL, 2021, 10 (10):
  • [10] Epidermal differentiation, inflammation, and serum levels of filaggrin and IgE in atopic dermatitis, classical prurigo nodularis and prurigo nodularis in AD
    Proksch, E.
    Hohmuth, A.
    Reimer, R.
    Foelster-Holst, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S219 - S219